Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has been ...

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without regular ...

News headlines Vertex Pharmaceuticals (VRTX) is gaining attention with a 25.6% year-over-year earnings growth forecast and strong pipeline advancements, despite concerns over its premium valuation.

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

This guide will walk you through integrating Looker with Generative AI Studio (Vertex AI) via Cloud Functions using the Looker Action API. Users can use the Looker Explore to examine data, then send ...

5.7 update: Updated the code to 5.7. I will have to update the readme over time 5.6 update: Updated the code to 5.6 with many small improvements and fixes. Apologies for the lack of response to PRs ...